Literature DB >> 24078696

IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa mice.

Caroline G McPhee1, Jason A Bubier, Thomas J Sproule, Giljun Park, Martin P Steinbuck, William H Schott, Gregory J Christianson, Herbert C Morse, Derry C Roopenian.   

Abstract

The pleiotropic cytokine IL-21 is implicated in the pathogenesis of human systemic lupus erythematosus by polymorphisms in the molecule and its receptor (IL-21R). The systemic lupus erythematosus-like autoimmune disease of BXSB.Yaa mice is critically dependent on IL-21 signaling, providing a model for understanding IL-21/IL-21R signaling in lupus pathogenesis. In this study, we generated BXSB.Yaa mice selectively deficient in IL-21R on B cells, on all T cells, or on CD8(+) T cells alone and examined the effects on disease. We found that IL-21 signaling to B cells is essential for the development of all classical disease manifestations, but that IL-21 signaling also supports the expansion of central memory, CD8(+) suppressor cells and broadly represses the cytokine activity of CD4(+) T cells. These results indicate that IL-21 has both disease-promoting and disease-suppressive effects in the autoimmune disease of BXSB.Yaa mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24078696      PMCID: PMC3807747          DOI: 10.4049/jimmunol.1300439

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis.

Authors:  Shreeram Akilesh; Daniel J Shaffer; Derry Roopenian
Journal:  Genome Res       Date:  2003-07       Impact factor: 9.043

2.  IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.

Authors:  Rachel Ettinger; Gary P Sims; Anna-Marie Fairhurst; Rachel Robbins; Yong Sing da Silva; Rosanne Spolski; Warren J Leonard; Peter E Lipsky
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

Review 3.  Lessons from BXSB and related mouse models.

Authors:  S Izui; N Ibnou-Zekri; L Fossati-Jimack; M Iwamoto
Journal:  Int Rev Immunol       Date:  2000       Impact factor: 5.311

4.  Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6.

Authors:  Katsutoshi Ozaki; Rosanne Spolski; Rachel Ettinger; Hyoung-Pyo Kim; Gang Wang; Chen-Feng Qi; Patrick Hwu; Daniel J Shaffer; Shreeram Akilesh; Derry C Roopenian; Herbert C Morse; Peter E Lipsky; Warren J Leonard
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

5.  The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs.

Authors:  Derry C Roopenian; Gregory J Christianson; Thomas J Sproule; Aaron C Brown; Shreeram Akilesh; Nadja Jung; Stefka Petkova; Lia Avanessian; Eun Young Choi; Daniel J Shaffer; Peter A Eden; Clark L Anderson
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

6.  A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation.

Authors:  E D Murphy; J B Roths
Journal:  Arthritis Rheum       Date:  1979-11

7.  beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice.

Authors:  G J Christianson; R L Blankenburg; T M Duffy; D Panka; J B Roths; A Marshak-Rothstein; D C Roopenian
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

8.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

9.  The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Authors:  Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; Gary Hill; Prue Hill; J Charles Jennette; Norella C Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

10.  Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.

Authors:  Magdalene Nakou; Eva D Papadimitraki; Antonios Fanouriakis; George K Bertsias; Christianna Choulaki; Nektaria Goulidaki; Prodromos Sidiropoulos; Dimitrios T Boumpas
Journal:  Clin Exp Rheumatol       Date:  2012-11-06       Impact factor: 4.473

View more
  27 in total

1.  Abrogated AID Function Prolongs Survival and Diminishes Renal Pathology in the BXSB Mouse Model of Systemic Lupus Erythematosus.

Authors:  Jing Zhu; Alayna N Hay; Ashley A Potter; Madison W Richwine; Thomas Sproule; Tanya LeRoith; John Wilson; Muneer G Hasham; Derry C Roopenian; Caroline M Leeth
Journal:  J Immunol       Date:  2020-01-27       Impact factor: 5.422

2.  Disruption of Pathogenic Cellular Networks by IL-21 Blockade Leads to Disease Amelioration in Murine Lupus.

Authors:  Jin-Young Choi; Abhinav Seth; Michael Kashgarian; Sonia Terrillon; Emma Fung; Lili Huang; Li Chun Wang; Joe Craft
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

Review 3.  Interleukin-21: a double-edged sword with therapeutic potential.

Authors:  Rosanne Spolski; Warren J Leonard
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

Review 4.  An update on lupus animal models.

Authors:  Wei Li; Anton A Titov; Laurence Morel
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

5.  The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.

Authors:  Jonathan Sitrin; Eric Suto; Arthur Wuster; Jeffrey Eastham-Anderson; Jeong M Kim; Cary D Austin; Wyne P Lee; Timothy W Behrens
Journal:  J Immunol       Date:  2017-07-10       Impact factor: 5.422

Review 6.  Spontaneous germinal centers and autoimmunity.

Authors:  Phillip P Domeier; Stephanie L Schell; Ziaur S M Rahman
Journal:  Autoimmunity       Date:  2017-02       Impact factor: 2.815

7.  Associations of Autoimmunity, Immunodeficiency, Lymphomagenesis, and Gut Microbiota in Mice with Knockins for a Pathogenic Autoantibody.

Authors:  Shweta Jain; Jerrold M Ward; Dong-Mi Shin; Hongsheng Wang; Zohreh Naghashfar; Alexander L Kovalchuk; Herbert C Morse
Journal:  Am J Pathol       Date:  2017-07-17       Impact factor: 4.307

Review 8.  Spatial and functional heterogeneity of follicular helper T cells in autoimmunity.

Authors:  Abhinav Seth; Joe Craft
Journal:  Curr Opin Immunol       Date:  2019-07-30       Impact factor: 7.486

Review 9.  IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation.

Authors:  Xiao-Mei Deng; Shang-Xue Yan; Wei Wei
Journal:  Cell Mol Immunol       Date:  2014-08-04       Impact factor: 11.530

10.  Precocious Interleukin 21 Expression in Naive Mice Identifies a Natural Helper Cell Population in Autoimmune Disease.

Authors:  Elisabeth A Marnik; Xulong Wang; Thomas J Sproule; Giljun Park; Gregory J Christianson; Sarah Kate Lane-Reticker; Shweta Jain; Theodore Duffy; Hongsheng Wang; Gregory W Carter; Herbert C Morse; Derry C Roopenian
Journal:  Cell Rep       Date:  2017-10-03       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.